Diabetes mellitus (DM) and Alzheimer's disease (AD) are expanding health problems. Recent evidence suggests that these diseases may be related, at least in some patients, and that DM may influence the initiation or progression of AD. Epidemiological and biochemical data suggest the nature of specific metabolic alterations in brain by which this may occur. The experiments described in this application will test the hypothesis that age, inherited susceptibilities to environmental factors, and DM combine to augment brain oxidative damage and neurodegeneration in the absence of stroke.
The Specific Aims proposed are (1) to determine brain oxidative damage, AGE formation, neurodegeneration, and complications of cerebrovascular disease in various models of experimental DM in young and old rodents alone and in combination with models of age-related oxidative damage to brain; (2) to determine whether interventions that suppress oxidative stress and/or AGE formation are effective at limiting brain oxidative damage, AGE formation, neurodegeneration, and cerebrovascuiar disease in models developed in Specific Aim 1; and (3) determine oxidative modifications on tau in cerebrospinal fluid (CSF) of probable AD patients to develop biomarkers for use with experimental therapies such as those investigated in Specific Aim 2. The candidate's immediate career goal is to redirect his area of research from cancer genetics and biology to the study of AD and related dementias. Specifically, the candidate will be instructed in methods of analysis of the chemical pathology of oxidized lipids and proteins in brain tissue and other biological samples. He will apply his understanding of genetic models of disease to studies that explore complex relations between genetic and environmental factors in the generation of oxidative damage to brain. The program developed in this application will allow him to integrate the training and experience he has received to date with the neuropathology training he is now undertaking to become a creative, productive, and independent physician/scientist focused on the mechanisms of age-related dementing illnesses.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01AG022040-03
Application #
6752891
Study Section
Special Emphasis Panel (ZAG1-ZIJ-8 (J1))
Program Officer
Phelps, Creighton H
Project Start
2002-07-15
Project End
2005-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
3
Fiscal Year
2004
Total Cost
$172,884
Indirect Cost
Name
University of Washington
Department
Pathology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Shaked, Gideon M; Chauv, Stephanie; Ubhi, Kiren et al. (2009) Interactions between the amyloid precursor protein C-terminal domain and G proteins mediate calcium dysregulation and amyloid beta toxicity in Alzheimer's disease. FEBS J 276:2736-51
Woltjer, Randall L; McMahan, Wendy; Milatovic, Dejan et al. (2007) Effects of chemical chaperones on oxidative stress and detergent-insoluble species formation following conditional expression of amyloid precursor protein carboxy-terminal fragment. Neurobiol Dis 25:427-37
Boutte, Angela M; Woltjer, Randall L; Zimmerman, Lisa J et al. (2006) Selectively increased oxidative modifications mapped to detergent-insoluble forms of Abeta and beta-III tubulin in Alzheimer's disease. FASEB J 20:1473-83
Woltjer, Randall L; Cimino, P J; Boutte, Angela M et al. (2005) Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease. FASEB J 19:1923-5
Wang, Qin; Woltjer, Randall L; Cimino, P J et al. (2005) Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. FASEB J 19:869-71
Woltjer, Randall L; Nghiem, William; Maezawa, Izumi et al. (2005) Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. J Neurochem 93:1047-56
Maezawa, Izumi; Jin, Lee-Way; Woltjer, Randall L et al. (2004) Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity. J Neurochem 91:1312-21
Woltjer, Randall L; Maezawa, Izumi; Ou, Joyce J et al. (2003) Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity. J Alzheimers Dis 5:467-76